Detalles de la búsqueda
1.
Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?
Clin Infect Dis
; 68(3): 435-443, 2019 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30481265
2.
Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16.
Euro Surveill
; 24(1)2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30621818
3.
Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal Vaccination.
Clin Infect Dis
; 61 Suppl 5: S563-9, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553689
4.
Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.
Clin Infect Dis
; 61 Suppl 5: S547-53, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553687
5.
Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso.
Clin Infect Dis
; 61 Suppl 5: S540-6, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553686
6.
Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays.
Clin Infect Dis
; 61 Suppl 5: S554-62, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553688
7.
Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Clin Infect Dis
; 61(11): 1637-44, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26374816
8.
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.
Clin Infect Dis
; 61 Suppl 5: S514-20, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553683
9.
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.
Clin Infect Dis
; 61 Suppl 5: S521-30, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553684
10.
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.
N Engl J Med
; 364(24): 2293-304, 2011 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-21675889
11.
Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccination.
Clin Infect Dis
; 52(11): 1317-23, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21596673
12.
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.
Lancet Infect Dis
; 21(5): 688-696, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428870
13.
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study.
Hum Vaccin Immunother
; 16(6): 1306-1312, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32233959
14.
Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants.
Open Forum Infect Dis
; 7(5): ofaa143, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32494580
15.
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.
Lancet Infect Dis
; 18(10): 1088-1096, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120069
16.
Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.
Vaccine
; 36(10): 1297-1303, 2018 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29397226
17.
Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt.
PLoS One
; 12(8): e0182575, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28796795
18.
Prospective survey on carriage of Neisseria meningitidis and protective immunity to meningococci in schoolchildren in Niamey (Niger): focus on serogroup W135.
Microbes Infect
; 8(8): 2098-104, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16777457
19.
Children with Haemophilus influenzae type b (Hib) vaccine failure have long-term bactericidal antibodies against virulent Hib strains with multiple capsular loci.
Vaccine
; 34(34): 3931-4, 2016 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27317452
20.
Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell disease.
Vaccine
; 34(36): 4327-34, 2016 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27395566